3 Exciting Biotech Stocks to Buy Right Now
Investing in biotechs is usually a high-risk, high-reward venture. Given the absurdly low probability of successfully bringing a drug to market (and the costs associated with the effort), development-stage companies in the sector can see their entire share value evaporate -- sometimes within a few days of releasing top-line results contrary to expectations.
With this in mind, it's can be safer to buy shares of biotech firms that already have their therapeutics past the regulatory hurdle. Here's how a company that's marketing an effective cancer treatment, one that's developed a life-saving COVID-19 vaccine, and another that's manufacturing a multi-purpose antidepressant can add some muscle to your biotech portfolio.
Image source: Getty Images.
Source Fool.com
